Helicobacter pullorum cytolethal distending toxin targets vinculin and cortactin and triggers formation of lamellipodia in intestinal epithelial cells

Journal of Infectious Diseases

Volumn 209, Issue 4, 2014, Pages 588-599

  Varon, Christine ^a,b   Mocan, Iulia ^a,b   Mihi, Belgacem ^a,b   Péré Védrenne, Christelle ^a,b   Aboubacar, Anriette ^a,b   Moraté, Christine ^a,b   Oleastro, Mónica ^c   Doignon, François ^a   Laharie, David ^a,b   Mégraud, Francis ^a,b   Ménard, Armelle ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Laboratoire de Bactériologie   (France)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

actin; adherence; cortactin; cytolethal distending toxin; epithelial cells; Helicobacter pullorum; isogenic mutant; lamellipodia; lentivirus; vinculin

Indexed keywords

ACTIN; ADHERENCE; CORTACTIN; CYTOLETHAL DISTENDING TOXIN; EPITHELIAL CELLS; HELICOBACTER PULLORUM; ISOGENIC MUTANT; LAMELLIPODIA; LENTIVIRUS; VINCULIN;

ACTIN CYTOSKELETON; BACTERIAL TOXINS; CACO-2 CELLS; CELL PROLIFERATION; CELL SHAPE; COCULTURE TECHNIQUES; CORTACTIN; GREEN FLUORESCENT PROTEINS; HELICOBACTER; HOST-PATHOGEN INTERACTIONS; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; LENTIVIRUS; MOLECULAR SEQUENCE DATA; MUTATION; PSEUDOPODIA; TRANSFECTION; VINCULIN;

EID: 84893272564     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit539     Document Type: Conference Paper

References (45)

1. Stanley J, Linton D, Burnens AP, et al. Helicobacter pullorum sp. nov.-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology 1994; 140:3441-9.
2. Steinbrueckner B, Haerter G, Pelz K, et al. Isolation of Helicobacter pullorum from patients with enteritis. Scand J Infect Dis 1997; 29:315-8.
3. Burnens AP, Stanley J, Morgenstern R, Nicolet J. Gastroenteritis associated with Helicobacter pullorum. Lancet 1994; 344:1569-70.
4. Bascunana P, Padrones I, Picazo JJ, Velasco AC. Diarrhea associated with Helicobacter pullorum in a child. Rev Esp Quimioter 2011; 24: 50-1.
5. Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 2004; 42: 2766-8.
6. Veijola L, Nilsson I, Halme L, et al. Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann Med 2007; 39:554-60.
7. Laharie D, Asencio C, Asselineau J, et al. Association between enterohepatic Helicobacter species and Crohn's disease: a prospective crosssectional study. Aliment Pharmacol Ther 2009; 30:283-93.
8. Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114:755-63.
9. Karagin PH, Stenram U, Wadstrom T, Ljungh A. Helicobacter species and common gut bacterial DNA in gallbladder with cholecystitis. World J Gastroenterol 2010; 16:4817-22.
10. Ponzetto A, Pellicano R, Leone N, et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000; 54:275-7.
11. Rocha M, Avenaud P, Ménard A, et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005; 54:396-401.
12. Pellicano R, Ménard A, Rizzetto M, Mégraud F. Helicobacters and liver diseases. Association or causation? Lancet Infect Dis 2008; 8: 254-60.
13. Casswall TH, Nemeth A, Nilsson I, Wadstrom T, Nilsson HO. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease. Scand J Gastroenterol 2010; 45: 160-7.
14. Varon C, Duriez A, Lehours P, et al. Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut 2009; 58:629-35.
15. Hynes SO, Ferris JA, Szponar B, et al. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic Helicobacters. Helicobacter 2004; 9:313-23.
16. Sirianni A, Kaakoush NO, Raftery MJ, Mitchell HM. The pathogenic potential of Helicobacter pullorum: possible role for the type VI secretion system. Helicobacter 2013; 18:102-11.
17. Chien CC, Taylor NS, Ge Z, Schauer DB, Young VB, Fox JG. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 2000; 49:525-34.
18. Young VB, Knox KA, Schauer DB. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 2000; 68:184-91.
19. Taylor NS, Ge Z, Shen Z, Dewhirst FE, Fox JG. Cytolethal distending toxin: a potential virulence factor for Helicobacter cinaedi. J Infect Dis 2003; 188:1892-7.
20. Young VB, Knox KA, Pratt JS, et al. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 2004; 72:2521-7.
21. Young VB, Chien CC, Knox KA, Taylor NS, Schauer DB, Fox JG. Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum. J Infect Dis 2000; 182:620-3.
22. Shen Z, Xu S, Dewhirst FE, et al. A novel enterohepatic Helicobacter species 'Helicobacter mastomyrinus' isolated from the liver and intestine of rodents. Helicobacter 2005; 10:59-70.
23. Shen Z, Feng Y, Rogers AB, et al. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect Immun 2009; 77:2508-16.
24. Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 2006; 74:4496-504.
25. Ge Z, Rogers AB, Feng Y, et al. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 2007; 9:2070-80.
26. Ceelen LM, Haesebrouck F, Favoreel H, Ducatelle R, Decostere A. The cytolethal distending toxin among Helicobacter pullorum strains from human and poultry origin. Vet Microbiol 2006; 113:45-53.
27. Avenaud P, Castroviejo M, Claret S, Rosenbaum J, Mégraud F, Ménard A. Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Biochem Biophys Res Commun 2004; 318:739-45.
28. Ceelen LM, Haesebrouck F, D'Herde K, et al. Mitotic catastrophe as a prestage to necrosis in mouse liver cells treated with Helicobacter pullorum sonicates. J Morphol 2009; 270:921-8.
29. Belibasakis GN, Mattsson A, Wang Y, Chen C, Johansson A. Cell cycle arrest of human gingival fibroblasts and periodontal ligament cells by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. APMIS 2004; 112:674-85.
30. Lara-TejeroM, Galan JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000; 290:354-7.
31. Lara-Tejero M, Galan JE. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun 2001; 69:4358-65.
32. Li L, Sharipo A, Chaves-Olarte E, et al. The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol 2002; 4:87-99.
33. Nishikubo S, Ohara M, Ueno Y, et al. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 2003; 278:50671-81.
34. Elwell C, Chao K, Patel K, Dreyfus L. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect Immun 2001; 69:3418-22.
35. Yamamoto K, Tominaga K, Sukedai M, et al. Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. Eur J Oral Sci 2004; 112:445-51.
36. Wising C, Magnusson M, Ahlman K, Lindholm L, Lagergard T. Toxic activity of the CdtB component of Haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector. APMIS 2010; 118:143-9.
37. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003; 77:8957-61.
38. Guerra L, Teter K, Lilley BN, et al. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 2005; 7:921-34.
39. Haglund CM, Welch MD. Pathogens and polymers: microbe-host interactions illuminate the cytoskeleton. J Cell Biol 2011; 195:7-17.
40. Selbach M, Backert S. Cortactin: an Achilles' heel of the actin cytoskeleton targeted by pathogens. Trends Microbiol 2005; 13:181-9.
41. Bulgin RR, Arbeloa A, Chung JC, Frankel G. EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42. Cell Microbiol 2009; 11:217-29.
42. Zheng J, Meng J, Zhao S, Singh R, Song W. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin-and Tolllike receptor-mediated activation of NF-kappaB. Infect Immun 2008; 76:4498-508.
43. Okuda J, Fukumoto M, Takeda Y, Nishibuchi M. Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun 1997; 65:428-33.
44. Neubauer C, Hess M. Tissue tropism of Helicobacter pullorum in specific pathogen-free chickens determined by culture and nucleic acid detection. Avian Dis 2006; 50:620-3.
45. Guidi R, Guerra L, Levi L, et al. Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell Microbiol 2013; 15:98-113.